Classes I–IV, two review tracks
Class I notification to Class IV full review; the Substantial Equivalent shortcut; and the January 2026 immediate-entry pathway for innovative tech.
Free field guide · PDF
South Korea MFDS Medical Device Registration2026 Field Guide
What manufacturers need to know before entering one of Asia's most demanding device markets — the KLH requirement, KGMP certification, and the new 2026 immediate-entry pathway.
- License validity
- 5 years
- KGMP cycle
- 3 years
- Immediate entry
- Jan 2026
Sourced from MFDS guidance and 2026 registration practice.
Download the free guide
Enter your work email and we'll send the PDF straight to your inbox.
What's inside
Five pages, zero fluff
Every figure in this guide traces to a named source — MFDS guidance and 2026 registration practice.
KLH and KGMP gatekeepers
The Korea License Holder files via SUGAM; KGMP audits (3-year cycle) are not ISO 13485; the product license runs five years.
What to plan for
Run KGMP in parallel, map the S.E. case first, budget for clinical scrutiny, and plan post-market through the KLH.
Sources & scope
- JNPMEDI APAC, Korea MFDS registration: timelines, KGMP, immediate-entry pathway.
- Freyr Solutions Korea, Korea License Holder and MFDS registration.
- ElendiLabs, MFDS, KGMP, and the Substantial Equivalent pathway.
- OMC Medical, South Korea medical device regulation overview.
This guide is market-access intelligence, not legal or regulatory advice. MFDS requirements change — professional review is required before business use.
Market Access Strategy Session
Entering Korea? Start with the full picture.
A Market Access Strategy Session maps your product's real MFDS pathway, timeline, and distributor landscape.
Professional review is required before business use.
Back to ghmap.io Questions? Talk to our team